
Rachel Shulman
@shulman_rachel
Instructor of Medicine | Nephrologist | @PennKidney
ID: 1280168950064701440
06-07-2020 15:57:26
9 Tweet
65 Followers
125 Following


Risk of CKD Progression and Quality of Care Indicators in the Primary Care Setting buff.ly/4506S66 (FREE) Oksana Harasemiw aminu bello Clara Bohm Navdeep Tangri SevenOaksCDIC U of M Rady Faculty #CKD


Excited for our publication in Hypertension! with Debbie Cohen MD ๐ฎ๐ฑ ๐บ๐ธ๐ฟ๐ฆ Adina Turcu Anand Vaidya & Greg Hundemer We asked: In patients with CKD and primary aldosteronism who underwent AVS, were there differences in outcomes and tolerability of treatment with adrenalectomy vs. MRA?

Cardiovascular Outcomes with Renin-Angiotensin System Inhibitors in Non-Proteinuric Chronic Kidney Disease: Findings from the CRIC Study@shulman_rachel Debbie Cohen MD ๐ฎ๐ฑ ๐บ๐ธ๐ฟ๐ฆ Jordy Cohen, MD, MSCE ahajrnls.org/3MYev5s


Out now: Really cool to contribute to this #CRIC_Study analysis led by Dr. Clara Fischman Pulse Pressure and Cardiovascular and Kidney Outcomes by Age in the Chronic Renal Insufficiency Cohort (CRIC) academic.oup.com/ajh/article-abโฆ Jordy Cohen, MD, MSCE Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS Larry Appel


TH-PO677 Daratumumab for Anti-CD20-Refractory Membranous Nephropathy fromย Tammy Yu, MD #KidneyWk #TeamRodbyLerma #Nephpearls


Stages of Cardiovascular-Kidney-Metabolic (CKM) syndrome ca. 2023 from Circulation American Heart Association #KidneyWk #Nephpearls ๐ pubmed.ncbi.nlm.nih.gov/37807924/
